SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC
Clinical trial NCT04106180 · UNKNOWN
Trial details
- NCT number
- NCT04106180
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2022-08-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.